Target Global Acquisition I (TGAA) Competitors $11.26 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends TGAA vs. BIOX, NETD, RRAC, UROY, PRPB, IPXX, PSTL, APPS, BRT, and REFIShould you be buying Target Global Acquisition I stock or one of its competitors? The main competitors of Target Global Acquisition I include Bioceres Crop Solutions (BIOX), Nabors Energy Transition Corp. II (NETD), Rigel Resource Acquisition (RRAC), Uranium Royalty (UROY), CC Neuberger Principal Holdings II (PRPB), Inflection Point Acquisition Corp. II (IPXX), Postal Realty Trust (PSTL), Digital Turbine (APPS), BRT Apartments (BRT), and Chicago Atlantic Real Estate Finance (REFI). These companies are all part of the "trading" industry. Target Global Acquisition I vs. Bioceres Crop Solutions Nabors Energy Transition Corp. II Rigel Resource Acquisition Uranium Royalty CC Neuberger Principal Holdings II Inflection Point Acquisition Corp. II Postal Realty Trust Digital Turbine BRT Apartments Chicago Atlantic Real Estate Finance Target Global Acquisition I (NASDAQ:TGAA) and Bioceres Crop Solutions (NASDAQ:BIOX) are both small-cap unclassified companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability. Is TGAA or BIOX more profitable? Bioceres Crop Solutions has a net margin of 0.68% compared to Target Global Acquisition I's net margin of 0.00%. Bioceres Crop Solutions' return on equity of 0.93% beat Target Global Acquisition I's return on equity.Company Net Margins Return on Equity Return on Assets Target Global Acquisition IN/A N/A N/A Bioceres Crop Solutions 0.68%0.93%0.38% Does the MarketBeat Community prefer TGAA or BIOX? Bioceres Crop Solutions received 28 more outperform votes than Target Global Acquisition I when rated by MarketBeat users. CompanyUnderperformOutperformTarget Global Acquisition IN/AN/ABioceres Crop SolutionsOutperform Votes2875.68% Underperform Votes924.32% Which has better earnings and valuation, TGAA or BIOX? Bioceres Crop Solutions has higher revenue and earnings than Target Global Acquisition I. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTarget Global Acquisition IN/AN/AN/AN/AN/ABioceres Crop Solutions$464.80M0.88$3.20M$0.04162.29 Does the media prefer TGAA or BIOX? In the previous week, Bioceres Crop Solutions had 1 more articles in the media than Target Global Acquisition I. MarketBeat recorded 3 mentions for Bioceres Crop Solutions and 2 mentions for Target Global Acquisition I. Bioceres Crop Solutions' average media sentiment score of 0.71 beat Target Global Acquisition I's score of 0.07 indicating that Bioceres Crop Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Target Global Acquisition I 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Bioceres Crop Solutions 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, TGAA or BIOX? Target Global Acquisition I has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Bioceres Crop Solutions has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500. Do analysts rate TGAA or BIOX? Bioceres Crop Solutions has a consensus target price of $12.25, suggesting a potential upside of 88.75%. Given Bioceres Crop Solutions' higher probable upside, analysts clearly believe Bioceres Crop Solutions is more favorable than Target Global Acquisition I.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Target Global Acquisition I 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABioceres Crop Solutions 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.33 Do insiders and institutionals hold more shares of TGAA or BIOX? 92.1% of Target Global Acquisition I shares are owned by institutional investors. Comparatively, 17.7% of Bioceres Crop Solutions shares are owned by institutional investors. 41.4% of Target Global Acquisition I shares are owned by insiders. Comparatively, 2.3% of Bioceres Crop Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryBioceres Crop Solutions beats Target Global Acquisition I on 11 of the 13 factors compared between the two stocks. Ad Opportunistic TraderMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...For a limited time, he's revealing his latest forecast here. Get Target Global Acquisition I News Delivered to You Automatically Sign up to receive the latest news and ratings for TGAA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TGAA vs. The Competition Export to ExcelMetricTarget Global Acquisition IHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$104.79M$418.28M$111.45M$8.53BDividend YieldN/A8.07%N/A4.14%P/E RatioN/A8.999.1315.14Price / SalesN/A99.659.47100.10Price / CashN/A74.9595.6034.08Price / BookN/A74.19525.095.02Net IncomeN/A$31.01M$2.17M$225.46M7 Day PerformanceN/A-0.90%-0.65%0.37%1 Month PerformanceN/A-0.51%-0.23%3.57%1 Year Performance2.93%11.58%15.41%29.43% Target Global Acquisition I Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TGAATarget Global Acquisition IN/A$11.26flatN/A+3.0%$104.79MN/A0.00N/ANews CoverageBIOXBioceres Crop Solutions3.0239 of 5 stars$6.63-1.3%$12.25+84.8%-37.4%$416.36M$464.80M165.79500News CoverageHigh Trading VolumeNETDNabors Energy Transition Corp. IIN/A$10.70+0.2%N/A+4.7%$407.88MN/A0.00N/APositive NewsRRACRigel Resource AcquisitionN/A$11.50-0.2%N/A+5.2%$368.81MN/A0.002,021UROYUranium Royalty2.7006 of 5 stars$2.88+3.6%$5.60+94.4%-2.5%$351.13M$31.62M48.0110Positive NewsPRPBCC Neuberger Principal Holdings IIN/A$4.15+2.7%N/A-3.5%$343.62MN/A0.004IPXXInflection Point Acquisition Corp. IIN/A$10.77+0.1%N/A+5.4%$336.56MN/A0.00N/AShort Interest ↑News CoveragePSTLPostal Realty Trust1.6433 of 5 stars$14.50-0.3%$15.75+8.6%+7.7%$333.94M$63.71M161.1340Upcoming EarningsNews CoveragePositive NewsAPPSDigital Turbine3.4202 of 5 stars$3.20flat$3.75+17.2%-28.8%$328.88M$516.11M-0.74840News CoverageGap UpBRTBRT Apartments3.4828 of 5 stars$16.29+0.4%$22.50+38.1%-1.3%$305.76M$93.62M-33.249Upcoming EarningsNews CoverageGap UpREFIChicago Atlantic Real Estate Finance4.229 of 5 stars$15.04-0.5%$20.00+33.0%+6.7%$295.09M$57.15M7.60N/AUpcoming Earnings Related Companies and Tools Related Companies BIOX Alternatives NETD Alternatives RRAC Alternatives UROY Alternatives PRPB Alternatives IPXX Alternatives PSTL Alternatives APPS Alternatives BRT Alternatives REFI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TGAA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Target Global Acquisition I Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Target Global Acquisition I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
